Pyridine

Pyridine

SCHEMBL3570902

N#CCc1ccnc(NC2CCCC2)n1.c1ccncc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.53
MAPK10 P53779 7/20 0.46
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
MAPK8 P45983 2/20 0.41
HRH4 Q9H3N8 1/20 0.41
RET P07949 1/20 0.40
IDH1 O75874 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
MAPK9 P45984 1/20 0.39
CTSS P25774 1/20 0.39
CDC7 O00311 1/20 0.39
PLK4 O00444 1/20 0.39
JAK2 O60674 1/20 0.39
CCNB2 O95067 1/20 0.39
MAP4K4 O95819 1/20 0.39
INSR P06213 1/20 0.39
CDK1 P06493 1/20 0.39
CSF1R P07333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL3566347 0.99 CTSK (0.55) CTSKMAPK10KDM4EGAAMAPK8
SCHEMBL6363768 0.87 CTSK (0.52) CTSKMAPK10KDM4EGAAHRH4
SCHEMBL3573948 0.83 CTSK (0.51) CTSKMAPK10KDM4EGAAHRH4
Pyridine SCHEMBL5622345 0.81 MAPK1 (0.34) CTSKMAPK10MKNK2
Pyridine SCHEMBL3574027 0.77 JAK2 (0.42) CTSKMAPK10KDM4EGAACCNE1
Pyridine SCHEMBL3571503 0.76 CTSK (0.43) CTSKMAPK10KDM4EGAACCNE1
Pyridine SCHEMBL3569988 0.75 MEN1 (0.45) CTSKMAPK10KDM4EGAAHRH4
Pyridine SCHEMBL3562760 0.72 JAK2 (0.44) CTSKMAPK10CCNE1CDK2JAK2
Pyridine SCHEMBL3569017 0.72 KCNH3 (0.44) KDM4EGAA
Pyridine SCHEMBL5622303 0.71 MEN1 (0.39) MAPK10CCNE1CDK2MAPK9JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855212-B2 Pyridinyl acetonitriles MERCK SERONO SA (CH) 2010-12-21 US claimed
US-20070060594-A1 Pyridinyl acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-03-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060594-A1 Pyridinyl acetonitriles GSK3B, GSK3A, MAPK3 CTSK 3419/4885MAPK10 86/4885KDM4E 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.